Form 8-K - Current report:
SEC Accession No. 0001999371-25-016108
Filing Date
2025-10-27
Accepted
2025-10-27 07:00:38
Documents
12
Period of Report
2025-10-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp_8k-102725.htm   iXBRL 8-K 31900
  Complete submission text file 0001999371-25-016108.txt   196537

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE tnxp-20251027.xsd EX-101.SCH 2990
3 XBRL LABEL FILE tnxp-20251027_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE tnxp-20251027_pre.xml EX-101.PRE 22342
14 EXTRACTED XBRL INSTANCE DOCUMENT tnxp_8k-102725_htm.xml XML 3543
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 251417424
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)